This figure shows PGR institution rates by technology. Within this relatively small data set, PGR institution rates varied, with TC 1600 patent challenges being instituted at a similar rate compared to that for all PGR institutions, while Orange Book-listed drug and biologic drug patent challenges were instituted less frequently. While the data available is still limited, we continue to monitor PGR decisions on those patents to determine whether this trend continues.
BiologicsHQ and materials published on BiologicsHQ are published for informational purposes only. Neither the information nor any opinion expressed on BiologicsHQ constitute legal advice, create an attorney-client relationship, or constitute a solicitation for business.